Methyl 2-amino-6-oxo-1,6-dihydropyrimidine-5-carboxylate, 98%, 100mg

N-(3-METHOXY-5-METHYL-2-PYRAZINYL)-2-[4-(1,3,4-OXADIAZOL-2-YL)PHENYL]-3-PYRIDINESULFONAMIDE, 98%, 5mg

5-Chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid, 98%, 500mg

tert-Butyl 3-hydroxy-3-(trifluoromethyl)azetidine-1-carboxylate, 95.0%, 5g

2-Chloro-4-fluoro-3-methyl-1-nitrobenzene, 95.0%, 10g

(S)-4-Benzyl-thiazolidine-2-thione, 98.0%, 5g

Sanilvudine, 95.0%, 10g

2-Propylcyclohexan-1-ol, 95%, 1g

2',7'-DICHLOROFLUORESCEIN DIACETATE, 95%, 5g

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 1g

2,2',4-Trifluoro-1,1'-biphenyl, 95.0%, 250mg

Tin(IV) oxide, min. 99.5%, pa, 100 g, plastic packaging.

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging